EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fabino Life Sciences's enterprise value is ₹64.7 Mil.
Fabino Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.5 Mil. Therefore, Fabino Life Sciences's EV-to-EBITDA for today is 41.77.
The historical rank and industry rank for Fabino Life Sciences's EV-to-EBITDA or its related term are showing as below:
BOM:543444'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 41.77 Med: 104.19 Max: 164.39
Current: 41.77
During the past 5 years, the highest EV-to-EBITDA of Fabino Life Sciences was 164.39. The lowest was 41.77. And the median was 104.19.
BOM:543444's EV-to-EBITDA is ranked worse than 87.62% of 711
companies
in the Drug Manufacturers industry
Industry Median: 14.89
vs BOM:543444: 41.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Fabino Life Sciences EV-to-EBITDA Historical Data
The historical data trend for Fabino Life Sciences's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fabino Life Sciences's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Life Sciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Fabino Life Sciences's EV-to-EBITDA falls into.
Fabino Life Sciences's current Enterprise Value is ₹64.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fabino Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Life Sciences (BOM:543444) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Fabino Life Sciences's PE Ratio for today is calculated as:
Fabino Life Sciences's share price for today is ₹30.43.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fabino Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.430.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Fabino Life Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Fabino Life Sciences (BOM:543444) Business Description
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543444 has been successfully added to your